IOVA
$13.62-7.47%
Iovance Biotherapeutics Inc.Stock · HealthcareRussell 2000 0.05%Nasdaq Composite 0.005%US Stock Market 0.002%Russell 3000 0.001%
Iovance Biotherapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Iovance Biotherapeutics Inc. total returns by year (2011–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $2.73 | $13.62 | 0.0% | +398.9% | |
| 2025 | $7.40 | $2.73 | 0.0% | -63.1% | |
| 2024 | $8.13 | $7.40 | 0.0% | -9.0% | |
| 2023 | $6.39 | $8.13 | 0.0% | +27.2% | |
| 2022 | $19.09 | $6.39 | 0.0% | -66.5% | |
| 2021 | $46.40 | $19.09 | 0.0% | -58.9% | |
| 2020 | $27.68 | $46.40 | 0.0% | +67.6% | |
| 2019 | $8.85 | $27.68 | 0.0% | +212.8% | |
| 2018 | $8.00 | $8.85 | 0.0% | +10.6% | |
| 2017 | $6.95 | $8.00 | 0.0% | +15.1% | |
| 2016 | $7.72 | $6.95 | 0.0% | -10.0% | |
| 2015 | $7.87 | $7.72 | 0.0% | -1.9% | |
| 2014 | $10.50 | $7.87 | 0.0% | -25.0% | |
| 2013 | $22.00 | $10.50 | 0.0% | -52.3% | |
| 2012 | $100.00 | $22.00 | 0.0% | -78.0% | |
| 2011 | $125.00 | $100.00 | 0.0% | -20.0% |
- Annualized
- -12.3%
- 2011–2026
- Average year
- -3.4%
- 15 full years
- Best year
- +212.8%
- 2019
- Worst year
- -78.0%
- 2012
- Positive years
- 5/15
- 33% up
Annualized (CAGR)
-12.3%
2011–2026
Average year
-3.4%
15 full years
Best year
+212.8%
2019
Worst year
-78.0%
2012
Positive years
5/15
33% up
Total return by period#
Annual
-200%0%200%
2011-20%'11
2012-78%'12
2013-52%'13
2014-25%'14
2015-1.9%'15
2016-10.0%'16
2017+15%'17
2018+11%'18
2019+213%'19
2020+68%'20
2021-59%'21
2022-67%'22
2023+27%'23
2024-9.0%'24
2025-63%'25
2026+399%'26
Methodology#
Total returns, dividends reinvested, measured on IOVA. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Iovance Biotherapeutics Inc.'s average annual return?
- Since 2011, Iovance Biotherapeutics Inc. (IOVA) has returned about -12.3% a year (the compound annual growth rate) and an average calendar-year return of -3.4%.
- What were Iovance Biotherapeutics Inc.'s best and worst years?
- Over 2011–2026, the best year was 2019 (+212.8%) and the worst was 2012 (-78.0%).
- How often is Iovance Biotherapeutics Inc. up in a year?
- 5 of the 15 full years since 2011 were positive — about 33% of the time.
More on Iovance Biotherapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100